536 related articles for article (PubMed ID: 17722066)
1. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis.
Ara J; See J; Mamontov P; Hahn A; Bannerman P; Pleasure D; Grinspan JB
J Neurosci Res; 2008 Jan; 86(1):125-35. PubMed ID: 17722066
[TBL] [Abstract][Full Text] [Related]
2. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
3. Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Lee DH; Steinacker P; Seubert S; Turnescu T; Melms A; Manzel A; Otto M; Linker RA
J Neuroinflammation; 2015 Oct; 12():187. PubMed ID: 26438180
[TBL] [Abstract][Full Text] [Related]
4. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis.
Nicholas AP; Sambandam T; Echols JD; Barnum SR
J Comp Neurol; 2005 Jun; 486(3):254-66. PubMed ID: 15844173
[TBL] [Abstract][Full Text] [Related]
5. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
Terayama R; Bando Y; Yamada M; Yoshida S
Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
[TBL] [Abstract][Full Text] [Related]
6. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
Bannerman P; Hahn A; Soulika A; Gallo V; Pleasure D
Glia; 2007 Jan; 55(1):57-64. PubMed ID: 17009237
[TBL] [Abstract][Full Text] [Related]
7. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
Mills Ko E; Ma JH; Guo F; Miers L; Lee E; Bannerman P; Burns T; Ko D; Sohn J; Soulika AM; Pleasure D
J Neuroinflammation; 2014 Jun; 11():105. PubMed ID: 24924222
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis.
Eixarch H; Calvo-Barreiro L; Costa C; Reverter-Vives G; Castillo M; Gil V; Del Río JA; Montalban X; Espejo C
Neurotherapeutics; 2020 Oct; 17(4):1988-2003. PubMed ID: 32681355
[TBL] [Abstract][Full Text] [Related]
9. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
10. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
Berard JL; Kerr BJ; Johnson HM; David S
Glia; 2010 Nov; 58(15):1816-26. PubMed ID: 20645407
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Inflammatory Effects of Oral-Formulated Tacrolimus in Mice with Experimental Autoimmune Encephalomyelitis.
Kim MJ; Sung JJ; Kim SH; Kim JM; Jeon GS; Mun SK; Ahn SW
J Korean Med Sci; 2017 Sep; 32(9):1502-1507. PubMed ID: 28776347
[TBL] [Abstract][Full Text] [Related]
13. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
14. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
Zagon IS; Rahn KA; Bonneau RH; Turel AP; McLaughlin PJ
Brain Res; 2010 Jan; 1310():154-61. PubMed ID: 19931226
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions.
Fuller ML; DeChant AK; Rothstein B; Caprariello A; Wang R; Hall AK; Miller RH
Ann Neurol; 2007 Sep; 62(3):288-300. PubMed ID: 17696121
[TBL] [Abstract][Full Text] [Related]
16. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T
Cells; 2019 Sep; 8(9):. PubMed ID: 31484369
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
18. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination.
Seifert T; Bauer J; Weissert R; Fazekas F; Storch MK
Acta Neuropathol; 2007 Feb; 113(2):195-203. PubMed ID: 17136549
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist.
Lou ZY; Zhao CB; Xiao BG
J Neurosci Res; 2012 Jan; 90(1):84-95. PubMed ID: 21922514
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
